Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 1;4(1):a002345.
doi: 10.1101/mcs.a002345. Print 2018 Feb.

Points to consider for sharing variant-level information from clinical genetic testing with ClinVar

Affiliations

Points to consider for sharing variant-level information from clinical genetic testing with ClinVar

Danielle R Azzariti et al. Cold Spring Harb Mol Case Stud. .

Abstract

Data sharing between laboratories, clinicians, researchers, and patients is essential for improvements and standardization in genomic medicine; encouraging genomic data sharing (GDS) is a key activity of the National Institutes of Health (NIH)-funded Clinical Genome Resource (ClinGen). The ClinGen initiative is dedicated to evaluating the clinical relevance of genes and variants for use in precision medicine and research. Currently, data originating from each of the aforementioned stakeholder groups is represented in ClinVar, a publicly available repository of genomic variation, and its relationship to human health hosted by the National Center for Biotechnology Information at the NIH. Although policies such as the 2014 NIH GDS policy are clear regarding the mandate for informed consent for broad data sharing from research participants, no clear guidance exists on the level of consent appropriate for the sharing of information obtained through clinical testing to advance knowledge. ClinGen has collaborated with ClinVar and the National Human Genome Research Institute to develop points to consider for clinical laboratories on sharing de-identified variant-level data in light of both the NIH GDS policy and the recent updates to the Common Rule. We propose specific data elements from interpreted genomic variants that are appropriate for submission to ClinVar when direct patient consent was not sought and describe situations in which obtaining informed consent is recommended.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
ClinVar display of data elements appropriate for public data sharing without explicit consent. (A) Standardized description of variant; (B) submitter's clinical significance assertion; (C) condition and inheritance pattern on which the submitter based the pathogenicity assertion; (D) name of submitter; (E) evidence on which the submitter based the clinical significance assertion. Selected views from ClinVar variation display for variation ID 43565 (https://www.ncbi.nlm.nih.gov/clinvar/variation/43565/ Accessed September 2017).

References

    1. ACMG Board of Directors. 2017. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics. Genet Med 19: 721–722. - PubMed
    1. American Medical Association. 2013. Genome Analysis and Variant Identification Policy D-460.971.
    1. Atreya RV, Smith JC, McCoy AB, Malin B, Miller RA. 2013. Reducing patient re-identification risk for laboratory results within research datasets. J Am Med Inform Assoc 20: 95–101. - PMC - PubMed
    1. Benitez K, Malin B. 2010. Evaluating re-identification risks with respect to the HIPAA privacy rule. J Am Med Inform Assoc 17: 169–177. - PMC - PubMed
    1. Cai R, Hao Z, Winslett M, Xiao X, Yang Y, Zhang Z, Zhou S. 2015. Deterministic identification of specific individuals from GWAS results. Bioinformatics 31: 1701–1707. - PMC - PubMed

Publication types

LinkOut - more resources